The model was always prove each molecule as an imaging agent then progress to therapeutic. The only thing that has changed here is that now the company is not under imminent threat of folding. The current trials continue to falter, timelines blown out, and 1 patient in 7 months indicates this one will blow out too.
Ann: First patient dosed in Phase 1 therapeutic lung cancer trial, page-6
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.15M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.6¢ | 2.4¢ | $35.08K | 1.363M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1210041 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 700000 | 1 |
View Market Depth
| Last trade - 14.50pm 01/11/2024 (20 minute delay) ? |
| RAD (ASX) Chart |